This site uses cookies to improve your experience. To help us insure we adhere to various privacy regulations, please select your country/region of residence. If you do not select a country, we will assume you are from the United States. Select your Cookie Settings or view our Privacy Policy and Terms of Use.
Cookie Settings
Cookies and similar technologies are used on this website for proper function of the website, for tracking performance analytics and for marketing purposes. We and some of our third-party providers may use cookie data for various purposes. Please review the cookie settings below and choose your preference.
Used for the proper function of the website
Used for monitoring website traffic and interactions
Cookie Settings
Cookies and similar technologies are used on this website for proper function of the website, for tracking performance analytics and for marketing purposes. We and some of our third-party providers may use cookie data for various purposes. Please review the cookie settings below and choose your preference.
Strictly Necessary: Used for the proper function of the website
Performance/Analytics: Used for monitoring website traffic and interactions
Reorder reagents. Delivering a 360-view through the pharma physician, laboratory and patient ecosystem, P360 designs and deploys capabilities that ensure the highest efficiencies and returns on sales operations, data management, clinical trials, patient centricity and IoT innovation. Notify of spill/cleaning needed. Open SOP software.
Pharmaceutical Technology has listed the leading API biologics (protein and peptide) companies in contract marketing based on its intel, insights, and decades-long experience in the sector. The document contains detailed information on the suppliers and their product offerings, alongside contact details to aid your purchasing or hiring decision.
Avacta has worked with Adeptrix Inc (Beverly, MA, USA) to develop a coronavirus antigen test that combines enrichment of the sample using Affimer® reagents with the analytical power of mass-spectrometry. 28, 2021 09:19 UTC. CAMBRIDGE & WETHERBY, England & BILLERICA, Mass.–(
ISO 13485:2016 is an internationally recognized quality standard intended to ensure the consistent design, development, production, installation, and sale of medical devices that are safe for their intended purposes. ” About Bio-Techne Corporation (NASDAQ: TECH). ” About Bio-Techne Corporation (NASDAQ: TECH).
The PR first sets out to establish that it has authority to regulate in vitro diagnostic “test systems” as devices, and not just the system’s individual components, such as reagents, instruments, specimen collection devices, and software.
The ban on the importation, manufacture, packing, sale, supply, possession, administration or use of unapproved COVID-19 vaccines therefore applies to all other vaccines, as well as to parallel imports of Comirnaty. Days after the media reports, CDSCO asked manufacturers and importers of tests and reagents to operate at maximum capacity.
Reagents supplier The Native Antigen Company has hired a new business development manager, Richard White , and senior product manager, Pardeep Sharda. Drawing on 25 years in clinical research, White will oversee Saama’s project delivery teams. The company is expanding its team after a move to a new facility to support growth and expansion.
The dramatic rise in online drug sales during the COVID-19 pandemic has increased the supply of counterfeit drugs, and many companies are now considering the addition of on-dose authentication for high-risk or high-value products. This had led to a corresponding rise in the supply of counterfeit drugs.
She is also a board member at BBI Solutions, a UK based diagnostic reagents and a Novo Holdings company. Aarti Shah, PhD former Chief Information and Digital Officer & Senior Vice President at Eli Lilly and Company between 2016 and 2021, a US-headquartered pharmaceutical company with approximately US$ 28 billion in sales in 2021.
The test offers an alternative to lab-developed tests (LDTs) or Assay Specific Reagents (ASR) combinations, potentially minimising variability and complexity in testing, reducing workload and alleviating risk for laboratories. billion in R&D and posted sales of CHF 61.5 In 2019, Roche invested CHF 11.7
Laboratory Implementation
Laboratory reagents for performing the test commercially have been designed and are currently being validated in preparation for regulatory submission to CMS/CLIA with a view to targeting sales in the USA initially. This is also expected to provide greater flexibility for potential distribution partners.
The test offers an alternative to lab-developed tests (LDTs) or Analyte Specific Reagent (ASR) combinations, potentially minimising variability and complexity in testing, reducing workload and alleviating risk for laboratories. billion in R&D and posted sales of CHF 61.5 IU/mL and an expanded linear range from 21.5
We organize all of the trending information in your field so you don't have to. Join 21,000+ users and stay up to date on the latest articles your peers are reading.
You know about us, now we want to get to know you!
Let's personalize your content
Let's get even more personalized
We recognize your account from another site in our network, please click 'Send Email' below to continue with verifying your account and setting a password.
Let's personalize your content